The Workflow of the Italian Central Laboratory for the National DNA Database
From the Legislative Framework to Continuous Innovation
Rosaliana Libro1, Mauro Zampiglia1* 1Central Laboratory of the National DNA Database «Grazia De Carli», Department of Penitentiary Administration, Ministry of Justice, Rome, Italy. *mauro.zampiglia@giustizia.it
Share this article
ABSTRACT
Italy established its National DNA Database (BDN-DNA) and the associated Central Laboratory in 2009, ratifying the Prüm Treaty through Law No. 85/2009 [1, 2]; both institutes became fully operational in 2017. The Central Laboratory is unique, among forensic laboratories, in analysing every reference sample with two independent autosomal STR kits, each targeting more than 20 loci, substantially reducing the probability of adventitious matches, and in routinely uploading Y-chromosome profiles alongside autosomal profiles. This article describes the legal framework and the operational/analytical workflow of the Italian system, from sample collection to loading profiles into the Database, along with some match statistics and case examples with investigative impact. Finally, we focus on the research, development and validation activities we carry out to continuously provide high processivity and quality of results, at the forefront of the latest scientific and technological innovations.
INTRODUCTION
Public familiarity with forensic DNA analysis has grown considerably in recent years, in no small part thanks to television crime dramas in which investigators trace a perpetrator from a single strand of DNA left at a crime scene. Real casework is rarely so immediate, but genetic profiles recovered from crime-scene evidence remain among the most powerful tools available for linking an individual to a criminal event, whether by direct comparison with a known suspect or by searching a forensic DNA database when no suspect has yet been identified.
Since England and Wales established the first national forensic DNA database in 1995, more than 50 countries, including the United States with CODIS (1998), have built comparable systems, each shaped by its own legal, ethical and technical framework. Italy joined this international effort relatively late but comprehensively, ratifying the 2005 Prüm Treaty on cross-border police cooperation through Law No. 85 of 30 June 2009 [1, 2], and building a national system that is today among the most analytically rigorous in Europe. This article focuses on that Italian system: its legal and organizational structure, its day-to-day laboratory workflow, and research, development and validation activities supporting its analytical choices.
THE ITALIAN NATIONAL DNA DATABASE (BDN-DNA)
Legal and institutional framework
In 2005, Belgium, Germany, Spain, France, Luxembourg, the Netherlands and Austria signed the Prüm Treaty (also known as Schengen III) to strengthen cross-border cooperation against terrorism, organized crime and illegal immigration, providing for the exchange of fingerprint, DNA and vehicle-registration data [2]. Italy ratified the Treaty through Law No. 85 of 30 June 2009 [1], which established two structurally separate bodies with distinct roles defined by the legislator: the National DNA Database (BDN-DNA), housed at the Central Directorate of Criminal Police within the Ministry of the Interior, and the Central Laboratory for BDN-DNA, housed within the Department of Penitentiary Administration of the Ministry of Justice. The same law defined the procedures for sample collection, analysis, storage and international data exchange through CODIS. The National DNA Database has been operational since 2017, following the implementing regulation set out in Presidential Decree No. 87/2016 [3], while the Central Laboratory began operating in December 2017 after obtaining accreditation under UNI CEI EN ISO/IEC 17025:2018 [4].
Under Article 9 of Law No. 85/2009 [1], the Central Laboratory is the only laboratory in Italy authorized to produce and submit reference profiles of individuals stopped or arrested (following validation by the judicial authority) or convicted of non-negligent offences, completed or attempted, for which arrest in flagrante delicto is permitted. Certain categories are excluded from sampling, among them offences not typically characterized by violence or threat, offences against the administration of justice, forgery, and bankruptcy offences. Law enforcement agencies and ISO/IEC 17025:2018-accredited specialist laboratories, by contrast, populate BDN-DNA with unknown profiles obtained from crime-scene evidence, and the database also holds profiles of missing persons and their relatives.
Sample collection and chain of custody
DNA is collected exclusively through buccal swabbing and spotted on chemically treated cards that change colour upon contact with saliva; the types of cards that have been used for sampling, from the beginning of the collection to date, are Copan Nucleic-Card™ and FTA EasiCollect™. Sample collection is linked to the AFIS (Automated Fingerprint Identification System) database of the Central Identity Records Office, which generates a unique, pseudo-anonymized collection code for each subject. Two samples are collected from each subject, on the territory or within penitentiary institutions. The cards are then allowed to dry, packaged and labelled with the anonymized barcode before being sent to the Central Laboratory. Of the two cards, one is analysed to generate the DNA profile for the BDN-DNA (Figure 1), while the other is retained by the laboratory and kept available for the judicial authorities.
Database architecture and analytical requirements
BDN-DNA uses CODIS software as its storage and search platform, structured in two tiers, “local” and “national”, with only profiles typed for at least 10 loci accessible at the national level, enabling international exchange through Italy’s national contact point; mixed-source profiles are excluded from the national tier unless a clearly distinguishable major contributor can be identified. The database is searched systematically both between and within collections, to identify offenders, detect erroneously duplicated subject profiles, and link crime-scene profiles to one another.
Uniquely among forensic laboratories internationally, the Central Laboratory analyses every biological sample using two different, independently validated STR chemistries, requiring concordance across at least 10 autosomal loci before a profile is eligible for database entry, a stricter standard than most comparable systems worldwide. The Laboratory is also among the very few internationally to routinely upload Y-chromosome profiles of reference subjects alongside autosomal profiles, a valuable addition in cases involving sexual offences or DNA mixtures. Reference profiles produced by the Laboratory therefore comprise 26 autosomal and 28 Y-STR markers, substantially reducing the probability of adventitious or erroneous matches.
Profile and sample retention
DNA profiles are retained in BDN-DNA for 30 years, extended to 40 years for offences carrying mandatory arrest in flagrante delicto or in cases of recidivism; profiles are deleted at the end of this period or following acquittal. Biological samples are destroyed 8 years after collection.

Figure 1: The different sources that populate the National DNA Database.
Investigative impact
Since becoming operational, BDN-DNA has repeatedly demonstrated its investigative value. One of its earliest major successes concerned the rape of a young woman in Milan in 2006, solved more than eleven years later when the offender’s profile was entered into the database following an unrelated arrest for theft. Database matching also proved decisive in identifying those responsible for releasing pepper spray during the crush at the Lanterna Azzurra nightclub in Corinaldo on the night of 7–8 December 2018, in which six young people died — the perpetrators were identified only after a match with a subject previously convicted of theft.
As of early August 2026, the database held approximately 180.000 subject profiles and 42.000 crime-scene profiles, and had produced around 7.300 confirmed national matches (stain-person), roughly 13.000 matches under the Prüm framework and more than 200 through INTERPOL, most concerning high-volume crimes such as theft and robbery, alongside homicide and sexual offences. Following a match, the identity of the pseudo-anonymized subject is decoded through AFIS and communicated to the police force that entered the corresponding crime-scene trace.
WORKFLOW OF THE ITALIAN CENTRAL LABORATORY FOR BDN-DNA
Our internal method consists of a series of mandatory phases used to obtain a genetic profile from a reference-subject card. Each phase is described below; the complete workflow of the Central Laboratory is illustrated in Figure 2.

Figure 2: Workflow and main analytical steps of the Central Laboratory for BDN-DNA. loci.
Sample receipt, collection and inspection
Each package, containing two samples collected in duplicate, undergoes a verification step performed by authorized Central Laboratory personnel, comprising:
- verification of packaging integrity;
- confirmation of correct labelling and documentation;
- registration in the laboratory information system;
- visual inspection to confirm suitability for analysis.
Only compliant samples proceed to the analytical phase.
Pre-amplification setup and punching
In each analytical session, up to 89 samples (cards) are processed using two different commercial kits, as required by law, and dispensed into two 96-well plates. From each card, a 1.2 mm punch is obtained using a semi-automated punching instrument (COPAN CPA200™ Semi-Automated Card Puncher) and transferred directly into PCR plates for direct amplification. The analyst selects the area of the chemically treated card showing the greatest colour change, presumed to be most enriched in genetic material.
Negative and positive controls are included in every analysis to exclude contamination and confirm successful amplification. For autosomal STR profiling, the following kits are used according to internally validated protocols:
- GlobalFiler™ Express (Thermo Fisher Scientific)
- PowerPlex® Fusion System (Promega)
- Investigator® 24plex GO! (QIAGEN)
- PowerPlex® 35GY System (Promega)
For male samples, when required by the judicial authority, Y-STR analysis is performed using:
- PowerPlex® Y23 System (Promega)
- Yfiler™ Plus (Thermo Fisher Scientific)
- Investigator® Argus Y-28 (QIAGEN)
Direct amplification
Direct PCR amplification is performed, without prior extraction or quantification, reducing sample-processing time. Amplifications are carried out on a Veriti™ or VeritiPro™ Thermal Cycler (Applied Biosystems), according to the thermal cycling profiles recommended by the kit manufacturers and using respective number of cycles internally validated.
STR detection by capillary electrophoresis
Amplified products are separated and detected by capillary electrophoresis (CE), using a Applied Biosystems 3500xL Genetic Analyzer (Thermo Fisher Scientific) or an 8-capillary Spectrum CE System (Promega). Automated allele calling from raw data is performed with GeneMapper™ ID-X (Thermo Fisher Scientific) or GeneMarker® HID for Spectrum (SoftGenetics and Promega), providing electropherogram of genetic profiles.
Data analysis and report
Data analysis consists of reviewing genetic profiles obtained after capillary electrophoresis to verify correct allele assignment and to identify and exclude potential electrophoretic artefacts. In compliance with Law No. 85/2009, each biological sample is processed using two different validated STR typing chemistries; a genetic profile is considered suitable for database entry only when the two profiles are concordant for at least 10 loci. Profiles fulfilling this requirement and meeting the Laboratory’s quality and validation criteria are approved for upload to BDN-DNA as reference profiles, becoming available for CODIS comparison against unknown forensic profiles collected by police forces at crime scenes.
RESEARCH, DEVELOPMENT AND INTERNAL VALIDATION STUDIES
The Central Laboratory for BDN-DNA must face several challenges in order to achieve high throughput while maintaining high-quality standards. In this context, the research and development unit closely follows scientific literature and technological advances in the field to identify new approaches that can be internally validated and implemented to further enhance performance.
For example, in recent years, we have modified the punching step, moving from a fully automated system to a semi-automated one. While maintaining the same level of reliability and sample traceability, the manual handling of cards by the operator has significantly reduced analysis times, thereby increasing sample throughput. On the other hand, from a quality perspective, we continuously evaluate and compare newly released STR genotyping kits, with the aim of identifying those offering the best performance for our sample types and workflow. The Central Laboratory has promptly adopted many of the technical and scientific innovations and improvements introduced by manufacturers, such as the use of mini-STR markers in multiplex assays to improve results obtained from degraded samples, as well as the implementation of quality indicators of amplifications, which help to determine whether a failed reaction is due to sample degradation or inhibition. Furthermore, we were among the first laboratories to introduce 8-dye kits and capillary electrophoresis (CE) systems, enabling the analysis of a greater number of markers in a single multiplex assay. This is exemplified by the PowerPlex® 35GY System (Promega), which allows us to type Amelogenin, 23 autosomal STR loci, 11 Y-STR loci, and two quality indicators in a single analysis.
All innovation and modification to our internal method are rigorously validated in accordance with ENFSI and SWGDAM guidelines [5, 6].
CONCLUSION
To date the Central Laboratory for BDN-DNA has analysed over 215.000 samples and uploaded nearly 180.000 reference profiles to CODIS, more than double the roughly 90.000 profiles held in late 2023, producing matches, some with international relevance under the Prüm and INTERPOL frameworks. This growth illustrates how database size, analytical robustness and processing capacity jointly determine investigative impact, and it underlines why continued validation of high-throughput kits and instrumentation, as reported here, is central to the Laboratory’s mission.
Looking ahead, a continuous improvement plan remains essential to evaluate and implement new technologies, analytical kits and instrumentation capable of further enhancing efficiency, robustness and operational performance without compromising the informative value and quality of genetic reference profiles.
REFERENCES
- Legge 30 giugno 2009, n. 85. Gazzetta Ufficiale della Repubblica Italiana, 2009.
- Council of the European Union. The Prüm Treaty. 27 May 2005.
- Decreto del Presidente della Repubblica 7 aprile 2016, n. 87. Gazzetta Ufficiale della Repubblica Italiana, 2016.
- UNI CEI EN ISO/IEC 17025:2018: Requisiti generali per la competenza dei laboratori di prova e taratura. UNI, 2018.
- European Network of Forensic Science Institutes (ENFSI), DNA Working Group. Guideline for internal validation/verification of various aspects of the DNA profiling process. ENFSI; 2023.
- Scientific Working Group on DNA Analysis Methods (SWGDAM). SWGDAM Validation Guidelines for DNA Analysis Methods. SWGDAM; 2016.
Header: Generated with AI